BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2025; 31(38): 111364
Published online Oct 14, 2025. doi: 10.3748/wjg.v31.i38.111364
Personalizing withdrawal time by insertion time to achieve target adenoma detection rate in colonoscopy
Bing-Xin Xu, Cong-Zhou Xu, Hao-Yan Zhang, Xu-Jin Chen, Bing-Ni Wei, Cheng Yang
Bing-Xin Xu, Cong-Zhou Xu, Hao-Yan Zhang, Xu-Jin Chen, Bing-Ni Wei, Cheng Yang, Department of Gastroenterology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, Jiangsu Province, China
Co-first authors: Bing-Xin Xu and Cong-Zhou Xu.
Author contributions: Yang C designed the study; Xu BX drafted the manuscript; Xu CZ and Zhang HY enrolled the participants; Xu BX and Xu CZ analyzed the data; Xu BX and Zhang HY interpreted the data; Chen XJ revised the manuscript; Xu BX, Xu CZ, Zhang HY, Chen XJ, Wei BN, Yang C critically reviewed and provided final approval of the manuscript; All authors were responsible for the decision to submit the manuscript for publication.
Supported by the Young and Middle-Aged Talents Program of Wuxi Health Commission, No. BJ2020011; Cohort Research Program of Wuxi Medical Center, Nanjing Medical University, No. WMCC202314; and Wuxi People’s Hospital 2024 “Wild Goose Array Talent” Reserve Discipline Leader, No. 2024-YZ-HBDTR-YC-2024.
Institutional review board statement: This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Wuxi People’s Hospital (No. KY24159).
Informed consent statement: Informed consent was waived for the retrospective portion of this study, as approved by the Institutional Review Board of Wuxi People’s Hospital. The requirement for consent was also waived for using retrospective data owing to the following Institutional Review Board criteria: De-identified data, minimal risk, and impracticality of re-consent. Written informed consent was obtained from all participants enrolled in the prospective cohort.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Cheng Yang, MD, Associate Professor, Doctor, Department of Gastroenterology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, No. 299 Qingyang Road, Liangxi District, Wuxi 214023, Jiangsu Province, China. yangchengds@163.com
Received: July 1, 2025
Revised: August 2, 2025
Accepted: September 5, 2025
Published online: October 14, 2025
Processing time: 108 Days and 15.2 Hours
Abstract
BACKGROUND

Adenoma detection rate (ADR), a key colonoscopy quality metric, varies with patient demographics and procedural factors.

AIM

To identify independent predictors of ≥ 25% ADR, develop a risk model, and propose withdrawal durations based on different insertion times.

METHODS

We retrospectively analyzed 830 cases using logistic regression and identified four key factors, validated in a prospective cohort of 5699 patients. Their importance was confirmed using random forest (RF), extreme gradient boosting (XGBoost) and light gradient boosting machine (LightGBM). Attempts to determine target-achieving withdrawal time by grouping cases based on insertion time and Cox regression were inconclusive. Using the 5699-case dataset, we developed a predictive model combining support vector machine (SVM) with XGBoost. We built a Shiny app using this model for clinical application.

RESULTS

Multivariate logistic regression identified age [odds ratio (OR) = 1.05; 95% confidence interval (CI): 1.03-1.08; P < 0.001], male (OR = 1.79; 95%CI: 1.32-2.41; P = 0.005), higher endoscopist experience (OR = 1.79; 95%CI: 1.20-2.68; P = 0.005), and longer withdrawal time (P < 0.001) as independent risk factors for colorectal adenoma. A nomogram demonstrated strong discrimination [area under the curve (AUC) = 0.720], with robust calibration and decision-curve performance. Feature importance via RF, XGBoost, and LightGBM confirmed key predictors. A hybrid model combining SVM regression for withdrawal-time estimation and XGBoost classification achieved stable results, with XGBoost reporting AUCs of 0.640 in training and 0.610 in testing, and similar validation outcomes. Deployed via a Shiny app for clinical use. However, model discrimination was modest (AUC: 0.61-0.64), suggesting that clinical utility requires further refinement.

CONCLUSION

A hybrid SVM-XGBoost model using four key endoscopic factors was independently validated and is available as a Shiny app, delivering real-time decision support to streamline endoscopy and enhance clinical outcomes.

Keywords: Colonoscopy; Withdrawal time; Insertion time; Adenoma detection rate; Machine learning

Core Tip: This study identifies four key predictors of ≥ 25% adenoma detection rate (ADR), age, sex, endoscopist experience, and withdrawal time and develops a validated hybrid support vector machine extreme gradient boosting model to predict ADR. Using data from 6529 colonoscopies, the model demonstrated stable performance and was implemented in a Shiny app for real-time clinical use. This innovative tool offers personalized guidance to optimize colonoscopy quality and improve clinical outcomes, representing a significant advancement in endoscopic decision support.